5th Africa Regulatory Conference: Together for patients – Transforming the regulatory ecosystem in Africa
This virtual event gathered stakeholders, including national regulatory authorities and pharmaceutical manufacturers, active in the regulatory field to discuss and explore future directions together as the continent moves towards the operationalisation of the African Medicines Agency.
Read more![](https://www.ifpma.org/wp-content/uploads/2023/02/Copy-of-Events-–-Featured-image-350x220.png)
Powerful, locally driven partnerships for health innovation in Africa
Read more![](https://www.ifpma.org/wp-content/uploads/2023/10/Collaborating-scientists_iStock-1446925365_2023-purchase-350x220.jpg)
HYPER
HYPER is an exciting IFPMA initiative dedicated to empowering, connecting, and mobilizing young leaders and future decision-makers in the innovative pharmaceutical industry.
Read more![](https://www.ifpma.org/wp-content/uploads/2022/11/partner-hyper-logo.png)
BeCOME
BeCOME (Beyond COVID Monitoring Excellence) was initiated to create a sustainable forum where experts in pharmacovigilance and pharmacoepidemiology from industry, public health, regulators, and academia can collectively meet.
Read moreINTREPID Alliance
INTREPID Alliance exists to accelerate the development of new treatments for emerging viral pandemic agents through coordinated early science and R&D, policy and advocacy and stakeholder engagement. INTREPID Alliance members collectively bring expertise in drug discovery, antiviral R&D and medicine manufacturing.
Read more![](https://www.ifpma.org/wp-content/uploads/2023/07/intrepid-alliance-logo.png)
#AlwaysInnovating: The pharmaceutical innovation journey
Pharmaceutical innovation – the core of our industry’s work – relies on pushing the limits of scientific knowledge to advance new medicines and vaccines for the benefit of people everywhere.
Read more![](https://www.ifpma.org/wp-content/uploads/2023/06/campaign-img-initiative-alwaysinnovating-350x250@2x-350x220.jpg)
The International Council for Harmonisation (ICH)
As a Standing Observer of ICH, IFPMA along with other ICH Members and Observers, has an important role in promoting global convergence toward ICH regulatory standards and their harmonized interpretation.
Read more![ICH logo](https://www.ifpma.org/wp-content/uploads/2024/03/ich-logo-1.png)
IPHA
Read more![](https://www.ifpma.org/wp-content/uploads/2023/07/IPHA_Logo-350x220.png)
Upholding ethics and business integrity
We develop, sustain, and champion a culture of trust and integrity in the health ecosystem, based on our Ethos of care, fairness, honesty, and respect.
Read more![](https://www.ifpma.org/wp-content/uploads/2022/11/areasofwork-ethics-01-350x220.jpg)
COVID-19
When the COVID-19 pandemic hit, the innovative pharmaceutical industry came together with the broader global health community and responded with unprecedented speed and scale, overcoming major hurdles along the way.
Read more![](https://www.ifpma.org/wp-content/uploads/2022/11/areasofwork-c19-01-350x220.jpg)